CIDP (CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY)
Clinical trials for CIDP (CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY) explained in plain language.
Never miss a new study
Get alerted when new CIDP (CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY) trials appear
Sign up with your email to follow new studies for CIDP (CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot may replace IV drip for nerve disorder
Disease control Recruiting nowThis study tests if a weekly shot under the skin (XEMBIFY) works as well as an IV infusion every three weeks (Gamunex-C) for people with CIDP, a chronic nerve condition. About 40 adults who are stable on IV treatment will first receive Gamunex-C for 19 weeks, then switch to XEMBI…
Matched conditions: CIDP (CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY)
Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control
Last updated May 26, 2026 06:05 UTC
-
New study tracks Real-Life impact of CIDP drug on 200 patients
Disease control Recruiting nowThis study follows 200 adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who are starting treatment with efgartigimod. Researchers will track changes in disability, grip strength, and quality of life over two years to see how well the drug works in real…
Matched conditions: CIDP (CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY)
Sponsor: argenx • Aim: Disease control
Last updated May 18, 2026 11:58 UTC